Role
Country
Date of registration
Address

Made In Tracker

Legal

About

Our data is continuously updated and sourced from EUDAMED, the European database for medical devices and in vitro diagnostics.

Subscribe to our monthly newsletter:

By subscribing, you accept the General Personal Data Protection Policy.

EUROPHARMA REGULATORY AFFAIRS SL — Authorised representative in Spain

Statistics for EUROPHARMA REGULATORY AFFAIRS SL

0Total Devices

0Basic UDI-DIs

0Not destined for EU market

0Certificates

0Valid

0Expiring < 6 months

0Countries

Certificate health for EUROPHARMA REGULATORY AFFAIRS SL

No certificates registered for this manufacturer.

Device catalog for EUROPHARMA REGULATORY AFFAIRS SL

No devices registered for this manufacturer.

MD Atlas update: May 27, 2026

EUROPHARMA REGULATORY AFFAIRS SL

ES-AR-000052453

Active

Address: CALLE ELECTRA , 32 33208 GIJON
Role: Authorised representative
Date of registration: Mar 4, 2026
Country: ES Spain

Sign in to open the EUDAMED record

The link to the official EUDAMED page is reserved for signed-in users. Create a free account to continue.

Password

No account yet?

About EUROPHARMA REGULATORY AFFAIRS SL

SRN: ES-AR-000052453
Role: Authorised representative
Country: Spain
Organization name: EUROPHARMA REGULATORY AFFAIRS SL
EU VAT number: B74248998
EORI: ESB74248998
Date of registration: Mar 4, 2026

Contact details for EUROPHARMA REGULATORY AFFAIRS SL

Address: 32, CALLE ELECTRA 33208 GIJON SPAIN
Phone: +34984841114
Email: ceo@eurofarma.es
Website: WWW.EUROFARMA.ES

Validator

Name: Agencia Española de Medicamentos y Productos Sanitarios
SRN: ES-CA-010
Phone: +34 (91) 822 5274
Email: sgps@aemps.es

Officers and regulatory representatives of EUROPHARMA REGULATORY AFFAIRS SL

RODRIGUEZ DAVID JOSE
Regulatory compliance in accordance with Regulation (EU) 2017/745, including technical documentation, post-market surveillance and vigilance.
Hidden

Sign in to view contact details

Contact details are reserved for signed-in users. Sign in or create an account to continue.